CHM 11.1% 1.0¢ chimeric therapeutics limited

funder

  1. 2,243 Posts.
    we have made numerous requests to Chameleon and various regulatory
    agencies for more detailed disclosure of Chameleon's litigation funding
    arrangements as we believe those arrangements are very material given
    Chameleon's financial position. The only information we have been able
    to establish is that the funder is Paul Lindholm.

    Two tranches of security for costs have been provided. The third is
    currently being negotiated.

 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.